PharmaEssentia Corporation
6446
Rankning i aktier
#1423
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Aktiekurs
$37.68
Marknadsvärde
$15.58B
Förändring (1 dag)
0.85%
Förändring (1 år)
149.38%
Land
TW
Handel PharmaEssentia Corporation (6446)
Kategori
Healthcare
Utdelningshistorik för PharmaEssentia Corporation (6446)
PharmaEssentia Corporation (aktiens symbol: 6446) har gjort totalt 1 utdelningsbetalningar.
Summan av alla utdelningar (justerat för aktiesplitar) är: $0.99
Utdelningsavkastning (TTM): 0.0012
Summan av alla utdelningar (justerat för aktiesplitar) är: $0.99
Utdelningsavkastning (TTM): 0.0012
Utdelningsbetalningar för PharmaEssentia Corporation (6446) från 2025 till 2026
Årliga utdelningsbetalningar
| År | Utdelning (justerat för aktiesplitar) | Ändra |
|---|---|---|
| 2026 (TTM) | $0.9898 | 0.00% |
| 2025 | $0.9898 | 0.00% |
Lista över alla utdelningsbetalningar
| År | Utdelning | Ändra |
|---|---|---|
| 2026 (TTM) | $1.10 | 0.00% |
| 2025 | $1.10 | 0.00% |
Utdelningar för liknande företag eller konkurrenter
| Företag | Antal utdelningsbetalningar | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
